Neon Bloom Inc (PK:NBCO)
Business Focus: Investment Management
Sep 28, 2023 08:00 am ET
Neon Bloom Signs Letter of Intent to Acquire Advanced Executive Sales, LLC
Acquisition Expected to Initially Increase Annual Revenues by $20 Million this Year
Aug 30, 2023 07:40 am ET
Bazelet Health Systems Inc., a Subsidiary of Neon Bloom, Inc. (OTC:NBCO), to Make an Organic Line of its PECSA Ingredient for 2024
COLUMBIA, MD / ACCESSWIRE / August 30, 2023 / Neon Bloom, Inc. (OTC PINK:NBCO), announced today that its subsidiary, Bazelet™ Health Systems Inc., will enter the $60B US Organic food and beverage industry in 2024 with the introduction of PECSA™ Organic.
Jul 24, 2023 03:15 pm ET
Neon Bloom, Inc. (OTC: NBCO) Returns to Current Information Status with OTC Markets Group
Company retains Global Business Strategies Inc. and appoints Fred Luke as Secretary and Board member
Jun 07, 2022 06:18 am ET
Bazelet™ to Supply Its Federally Legal Cannabis Genetics to DEA Approved Research Entities for Rigorous Scientific Research on the Clinical Effects of Cannabigerol (CBG)
Neon Bloom, Inc. (OTC: NBCO): Bazelet Health Systems™, a wholly owned subsidiary of Neon Bloom, is proud to announce the endowment of a program known as ‘cERI’ (cannabis Education & Research Initiative). The program encompasses the donation by...
May 06, 2022 06:00 am ET
Bazelet™ to Introduce its PECSA™ Ingredient at the National Restaurant Association Show May 21-24, 2022, Chicago, IL.
Neon Bloom Inc. (OTC: NBCO): Bazelet Health Systems, Inc. (Bazelet™), a wholly owned subsidiary of Neon Bloom Inc., announces they will exhibit at the National Restaurant Association Show May 21-24, 2022, at the Chicago's McCormick Place. Bazelet...
Apr 29, 2022 11:50 am ET
Neon Bloom: Invitation to Investor Summit Group's Q2 In-Person Conference
Columbia, Maryland--(Newsfile Corp. - April 29, 2022) - Neon Bloom (OTC Pink: NBCO) today announced that Walter Tabaschek, COO/CFO will be attending The Q2 Investor Summit Group - In-Person. This presentation is about a genetic operating platform called Cannabis Zero™, that introduces patented 0% THC cannabis plants and a patented 0% THC food ingredient called PECSA™.
Apr 28, 2022 06:00 am ET
Bazelet Health Announces a U.S. Scientific Achievement and Scientific Proof of Cannabis America™, its 0% THC Tri-Purpose Cannabis Plant for Global Markets
Neon Bloom Inc. (OTC: NBCO) - Bazelet Health Systems, Inc. (Bazelet™), a wholly owned subsidiary of Neon Bloom Inc., announces that its Cannabis America™ plant produced 0% tetrahydrocannabinol (THC) in a full panel chemical analysis conducted by...
Apr 21, 2022 06:00 am ET
International Senior Finance and Operations Executive named Chief Financial Officer and Chief Operating Officer of Neon Bloom’s wholly owned subsidiary Bazelet™
Neon Bloom Inc. (OTC: NBCO) - Bazelet Health Systems, Inc. (Bazelet™), a wholly owned subsidiary of Neon Bloom Inc., named Walter Tabaschek, as its Chief Operating & Financial Officer. Mr. Tabaschek comes to Bazelet™ after nearly a two-decade...
Apr 06, 2022 08:18 am ET
Bazelet Health announces PECSA™, its new federally legal, non-GMO plant-based cannabis ingredient for US and export markets
Neon Bloom Inc. (OTC: NBCO) -- Bazelet Health Systems, Inc. (Bazelet™), a wholly owned subsidiary of Neon Bloom Inc., announces a first-to-market, federally legal cannabis ingredient: PECSA™, its plant-based, patent-pending, trademarked ingredient...
Jan 05, 2022 01:15 pm ET
Neon Bloom increases authorized Common Stock and creates Series B Preferred Stock
Neon Bloom, Inc. (OTC: NBCO), through its wholly owned subsidiary Bazelet Health Systems, Inc., is a professional healthcare organization leading cannabis science and the development of federally compliant, non-psychoactive cannabis products. On...
Nov 17, 2021 01:33 pm ET
Bazelet™ issues Licensing agreement for non-psychoactive cannabis production for the FDA and Florida legislative involvement
Neon Bloom, Inc. (OTC: NBCO) Bazelet Health Systems (the Company or Bazelet), a wholly owned subsidiary of Neon Bloom, announced it has executed a licensing agreement with Floresta, LLC in Tallahassee, Florida, to manufacture Panakeia™ plants,...
Oct 21, 2021 02:23 pm ET
Bazelet™ advances non-psychoactive cannabis with Cornell University through its 2021 Fiber and Dual-Purpose Trials
ORLANDO, Fla., Oct. 21, 2021 /PRNewswire/ -- (OTC: NBCO), Bazelet Health Systems, a wholly owned subsidiary of Neon Bloom, is proud to announce three of its industrial cannabis genetics were top performers in the "2021 Fiber and Dual-Purpose Strip Trials" conducted by Cornell University in Geneva, New York. According to Cornell's report on the trials, Bazelet genetics outperformed all others, highlighting unmatched seed weight, germination rates, plant density per ft2 and plant height.
Sep 28, 2021 08:18 am ET
Bazelet Health and Sattviko to produce plant-based superfoods for the global marketplace
ORLANDO, Fla., Sept. 28, 2021 /PRNewswire/ -- Bazelet Health Systems Inc., (Bazelet) a wholly owned subsidiary of Neon Bloom, Inc. (OTC:NBCO) announced it recently signed an agreement with Sattviko, a packaged food manufacturer. This partnership will produce a line of superfoods infused with Bazelet Health's non-psychoactive legal cannabis ingredients.
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.